Basal cell carcinoma of skin of other parts of face
ICD-10 C44.319 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of other parts of face.
Basal cell carcinoma (BCC) is the most common form of skin cancer, primarily arising from the basal cells in the epidermis. This specific code, C44.319, refers to BCC located on other parts of the face, excluding the eyelids, ears, and lips. BCC is often associated with prolonged sun exposure, which leads to DNA damage in skin cells. Clinically, BCC may present as a pearly nodule, a flat scar-like lesion, or a non-healing sore. Diagnosis is typically confirmed through a biopsy. Treatment options include surgical excision, Mohs micrographic surgery, cryotherapy, and topical chemotherapy. Surgical margins are crucial in BCC management to ensure complete removal and minimize recurrence. Reconstruction may be necessary post-excision, especially for larger lesions or those in cosmetically sensitive areas. The prognosis for BCC is generally excellent, but careful monitoring is essential due to the potential for local recurrence and the risk of developing additional skin cancers, particularly in patients with a history of significant sun exposure.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Diagnosis and treatment of BCC, follow-up care, and management of multiple skin cancers.
Ensure accurate documentation of the lesion's characteristics and treatment outcomes.
Comprehensive treatment plans, including surgical and non-surgical interventions.
Management of advanced BCC cases requiring systemic therapy or clinical trials.
Document any multidisciplinary approaches to treatment and patient history.
Used for excising BCC with high risk of recurrence.
Document the extent of the excision and margins.
Dermatologists should ensure detailed operative notes.
The primary cause of basal cell carcinoma is prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, which damages the DNA in skin cells.
